{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:25:45Z","timestamp":1648736745586},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1986,4,1]],"date-time":"1986-04-01T00:00:00Z","timestamp":512697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blut"],"published-print":{"date-parts":[[1986,4]]},"DOI":"10.1007\/bf00321080","type":"journal-article","created":{"date-parts":[[2004,10,18]],"date-time":"2004-10-18T23:22:21Z","timestamp":1098141741000},"page":"211-219","source":"Crossref","is-referenced-by-count":3,"title":["High dosage desferrioxamine therapy in a female patient with acquired aplastic anaemia and transfusion siderosis"],"prefix":"10.1007","volume":"52","author":[{"given":"H.","family":"Breithaupt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Heckers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Pralle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Guttmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Bleyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Graef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Jundt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","unstructured":"AMA Drug Evaluations, 4th edition, p. 1447, Publishing Science Group, Littleton 1980"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1055\/s-0028-1129239","volume":"103","author":"H Arnold","year":"1978","unstructured":"Arnold H, Wehinger H, Deus G, L\u00f6hr GW (1978) Kontrollierte Desferrioxamin-Therapie bei kongenitaler An\u00e4mie und Transfusionssiderose. Dtsch Med Wochenschr 103: 1240?1244","journal-title":"Dtsch Med Wochenschr"},{"key":"CR3","first-page":"62","volume":"25","author":"R Br\u00fcckner","year":"1967","unstructured":"Br\u00fcckner R, Hess R, Keberle H, Pericin C, Tripod I (1967) Tierexperimentelle pathologische Linsenver\u00e4nderungen nach langdauernder Verabreichung hoher Dosen von Desferal. Helv Physiol Pharmacol Acta 25: 62?77","journal-title":"Helv Physiol Pharmacol Acta"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF01635436","volume":"31","author":"G Cartei","year":"1975","unstructured":"Cartei G, Barbui T, Cazzavillan M, Chisesi T, Dini E (1975) Desferrioxamine B. Reversible side effects of high daily doses. Blut 31: 11?16","journal-title":"Blut"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/0002-9343(77)90551-4","volume":"63","author":"B Cooper","year":"1977","unstructured":"Cooper B, Bunn HF, Propper RD, Nathan DG, Rosenthal DS, Moloney WC (1977) Treatment of iron overload in adults with continuous parenteral desferrioxamine. Am J Med 63: 958?966","journal-title":"Am J Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2141.1969.tb01371.x","volume":"17","author":"RLC Cumming","year":"1969","unstructured":"Cumming RLC, Smith JA, Goldberg A (1969) Clinical and laboratory studies on the action of desferrioxamine. Brit J Haemat 17: 257?263","journal-title":"Brit J Haemat"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(83)90170-8","volume":"2","author":"SC Davies","year":"1983","unstructured":"Davies SC, Marcus RE, Hungerford JL, Miller MH, Arden GB, Huehns ER (1983) Ocular toxicity of high-dose intravenous desferrioxamine. The Lancet 2: 181?184","journal-title":"The Lancet"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0002-9343(68)90012-0","volume":"45","author":"LA Harker","year":"1968","unstructured":"Harker LA, Funk DD, Finch CA (1968) Evaluation of storage iron by chelates. Am J Med 45: 105?115","journal-title":"Am J Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood.V51.3.415.415","volume":"51","author":"Ch Hershko","year":"1978","unstructured":"Hershko Ch (1978) Determinants of fecal and urinary iron excretion in desferrioxamine-treated rats. Blood 51: 415?423","journal-title":"Blood"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1749-6632.1965.tb54077.x","volume":"119","author":"H Keberle","year":"1964","unstructured":"Keberle H (1964) The biochemistry of desferrioxamine and its relation to iron metabolism. Ann N Y Acad Sci 119: 758?768","journal-title":"Ann N Y Acad Sci"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(81)92227-3","volume":"2","author":"KG Miller","year":"1981","unstructured":"Miller KG, Rosenwasser LJ, Bessette J-AM, Beer DJ, Rocklin RE (1981) Rapid desensitation for desferrioxamine anaphylactic reaction. The Lancet 2: 1059","journal-title":"The Lancet"},{"key":"CR12","first-page":"177","volume":"12","author":"AW Nienhuis","year":"1976","unstructured":"Nienhuis AW, Delea C, Aamodt R, Bartter R, Anderson WF (1976) Evaluation of desferrioxamine and ascorbic acid for the treatment of chronic iron overload. Birth Defects 12: 177?185","journal-title":"Birth Defects"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1749-6632.1974.tb20588.x","volume":"232","author":"RT O'Brien","year":"1974","unstructured":"O'Brien RT (1974) Ascorbic acid enhancement of desferrioxamine-induced urinary iron excretion in thalassemia major. Ann N Y Acad Sci 232: 221?225","journal-title":"Ann N Y Acad Sci"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0006-2952(66)90114-6","volume":"15","author":"G Peters","year":"1966","unstructured":"Peters G, Keberle H, Schmid K, Brunner H (1966) Distribution and renal excretion of desferrioxamine and ferrioxamine in the dog and in the rat. Biochem Pharmacol 15: 93?109","journal-title":"Biochem Pharmacol"},{"key":"CR15","first-page":"323","volume":"310","author":"AM Pierides","year":"1984","unstructured":"Pierides AM, Myli MP (1984) Iron and aluminium osteomalacia in hemodialysis patients. N Engl J Med 310: 323","journal-title":"N Engl J Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1182\/blood.V60.2.288.288","volume":"60","author":"MJ Pippard","year":"1982","unstructured":"Pippard MJ, Callender ST, Finch CA (1982) Ferrioxamine excretion in iron-loaded man. Blood 60: 288?294","journal-title":"Blood"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2141.1982.tb03883.x","volume":"52","author":"MJ Pippard","year":"1982","unstructured":"Pippard MJ, Johnson DK, Finch CA (1982) Hepatocyte iron kinetics in the rat explored with an iron chelator. Brit J Haematol 52: 211?224","journal-title":"Brit J Haematol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJM197708252970804","volume":"297","author":"RD Propper","year":"1977","unstructured":"Propper RD, Cooper B, Rufo RR, Nienhuis AW, Anderson WF, Bunn HF, Rosenthal A, Nathan DG (1977) Continuous subcutaneous administration of deferoxamine in patients with iron overload. N Engl J Med 297: 418?423","journal-title":"N Engl J Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1056\/NEJM197606242942603","volume":"294","author":"RD Propper","year":"1976","unstructured":"Propper RD, Shurin SB, Nathan DG (1976) Reassessment of the use of desferrioxamine B in iron overload. N Engl J Med 294: 1421?1423","journal-title":"N Engl J Med"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0584-8547(71)80026-5","volume":"26","author":"JTH Roos","year":"1971","unstructured":"Roos JTH, Price WJ (1971) Mechanism of interference and releasing action in atomic absorption spectrometry. I. Effect of citric acid on iron. Spectrochim Acta 26 B: 279?282","journal-title":"Spectrochim Acta"},{"key":"CR21","first-page":"348","volume":"17","author":"Y Sidi","year":"1981","unstructured":"Sidi Y, Shaklai M, Liban E, Pinkhas J (1981) Continuous high-dose intravenous desferrioxamine treatment for iron overload. Israel J Med Sci 17: 348?351","journal-title":"Israel J Med Sci"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2141.1969.tb01407.x","volume":"17","author":"AA Wapnick","year":"1969","unstructured":"Wapnick AA, Lynch SR, Charlton RW, Seftel HC, Bothwell TH (1969) The effect of ascorbic acid deficiency on desferrioxamine induced urinary iron excretion. Brit J Haemat 17: 563?569","journal-title":"Brit J Haemat"},{"key":"CR23","first-page":"338","volume":"6","author":"HS Waxman","year":"1969","unstructured":"Waxman HS, Brown EB (1969) Clinical usefulness of iron chelating agents. Prog in Hematol 6: 338?373","journal-title":"Prog in Hematol"},{"key":"CR24","unstructured":"Wissenschaftliche Tabellen Geigy: Teilband K\u00f6rperfl\u00fcssigkeiten, 8. Auflage, Basel, 1977"},{"key":"CR25","first-page":"1370","volume":"57","author":"F W\u00f6hler","year":"1962","unstructured":"W\u00f6hler F (1962) Die Therapie der H\u00e4mochromatose. Med Klin 57: 1370?1376","journal-title":"Med Klin"},{"key":"CR26","unstructured":"World Health Organization: Report of a WHO working group on the community control of hereditary anaemias. Geneva, 9?11 November, 1981"}],"container-title":["Blut"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00321080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00321080\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00321080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T10:55:35Z","timestamp":1585911335000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00321080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1986,4]]}},"alternative-id":["BF00321080"],"URL":"https:\/\/doi.org\/10.1007\/bf00321080","relation":{},"ISSN":["0006-5242","1432-0584"],"issn-type":[{"value":"0006-5242","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,4]]}}}